Big Gain For Renalytix AI plc
Mon, Feb 12, 2024 at 07:09 PM
Renalytix AI plc (RNLX:NASDAQ) shot up at $1.25, representing a gain of 228%. On Mon, Feb 12, 2024, RNLX:NASDAQ hit a New 2-Week High of $1.25. The stock appeared on our News Catalysts scanner on Fri, Feb 09, 2024 at 11:34 AM in the 'MISCELLANEOUS' category. From Mon, Jan 29, 2024, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Mon, Feb 12, 2024 at $2.4 with a volume of 50M+.
About Renalytix AI plc (RNLX:NASDAQ)
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally.
Top 10 Gainers:
- Beamr Imaging Ltd. (BMR:NASDAQ), 371.56%
- Renalytix AI plc (RNLX:NASDAQ), 228%
- Millennium Group International Holdings Limited (MGIH:NASDAQ), 201.94%
- SRAX, Inc. (SRAX:NASDAQ), 172.73%
- Invitae Corporation (NVTA:NYSE), 91.79%
- BranchOut Food Inc. (BOF:NASDAQ), 69.86%
- Nano Labs Ltd (NA:NASDAQ), 65.89%
- Vinco Ventures Inc. (BBIG:NASDAQ), 56.25%
- Quantum FinTech Acquisition Corporation (QFTA:NYSEMKT), 51.33%
- Quantum FinTech Acquisition Corporation (QFTA:NYSE), 51.33%